Moccona launches flavour infused coffee TVC via bcg2

mocconaMoccona is launching a new brand TVC to support a new range of coffees in Australia. The coffee is infused with hints of smooth Caramel, delicate Vanilla and roasted Hazelnut flavour and will launch into New Zealand in 2013.

The spot was shot by Gregor Nicholas in Santiago Chile with Flying Fish as production house. The ad is part of a trans-Tasman launch campaign and builds upon the premium European imagery of romance that Moccona has established in Australia with iconic communications like the much loved Cinderella and Candles campaigns.

bcg2 is agency of record for the Moccona brand in New Zealand and was asked to lead this launch project in June. “It’s great to be working on both sides of the Tasman for the launch of an exciting new development for the Moccona brand.” Says Michael Jarvis bcg2 Managing Director.

“Moccona gives you the opportunity to tell wonderful stories. It’s a brand that holds a special place in the hearts of its drinkers so winning the opportunity to create the next chapter was a great privilege -and responsibility.” Says James Blackwood bcg2 CEO & ECD. “This commercial steps beyond the iconic jar and focuses on aroma which is new territory for the brand but perfect for ‘flavour infused’. Everyone put their heart and soul into the project and Gregor did a fantastic job of bringing the script to life and injecting a contemporary aesthetic.”

To view ad click here – Moccona \’The Kiss\’

TVNZ NZ Marketing Awards, Multiple Winners – Pfizer New Zealand “Avigra” campaign

Congratulations to bcg2 Health’s client, Pfizer New Zealand whose Avigra campaign was one of the biggest winners at the 2012 Marketing Association TVNZ Marketing Awards.

The Avigra Campaign won awards in the following categories;

Innovation – Judges choice

Marketing Leadership – Judges choice

Category – Consumer

Category – Lifestyle / Travel / Leisure

The TVNZ Marketing Awards judges commented, “The idea was revolutionary for the category. They had an existing great brand and the category always says at the end of patents then it’s open for generics. But they turned that assumption on its head and said ‘no, we’re going to use our already strong brand to create a new brand that leverages everything off it, but expands the category at the same time’. They had to go right to the very top of the organisation to get buy in. It was a really big challenge, a really big risk and it really, really worked”

letthegames timtoget morebang

 

Unlocking indulgent moments with Moccona

moccona2bcg2 recently created a 6-week promotion to tie-in with Moccona’s ‘Room Key’ TVC. We gave consumers the chance to ‘unlock’ some indulgent prizes, simply by buying Moccona. The promotion was driven via online, TV and in-store advertising and directed consumers to a purpose-built Moccona website to go in the draw to win. Prizes ranged from Gold Class movie tickets, magazine subscriptions, beauty treatments and more. Runner-up prizes of Moccona coffee were awarded too.

The promotion was a big success for Moccona – and even better, there were plenty of happy customers who got to enjoy some indulgent moments.

Supporting Elements:

–       15” Promo TVC

–       In store Shelf talker

–       On pack sticker

–       Interactive Microsite

–       eDM to Moccona database

–       Online banners

–       YouTube advertising

“Supplier of the Year, Best Marketing Campaign” at Pharmacy Awards

hardchoicebcgHealth and Pfizer New Zealand have won the award for “Supplier of the Year, Best Marketing Campaign” at the New Zealand Pharmacy Awards dinner. The award was given for the current Avigra (generic Viagra) Campaign.

Uniquely both Pfizer, the manufacturer and bcg2, the advertising agency submitted a joint entry to this award illustrating the strong team work that took place in order to create this highly successful campaign.

Stuart Ogden, bcg2 Health GM, said “Pharmacy is a key channel for the healthcare market, so it’s great to be recognised for best in class work.”  “This highly successful campaign has not only defended the majority market share held by Viagra but has substantially grown the overall Pfizer share of the mens’ erectile dysfunction market.”